From: Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
Group A | Group B | P value | |||
---|---|---|---|---|---|
Alb < 4.0 g/L | Alb ≥ 4.0 g/L | ||||
n = 25 | n = 429 | ||||
Age (mean ± SD), years | 68.8 ± 14.5 | 51.9 ± 15.9 | <0.0001 | ||
Sex (male/female) | 16/9 | 180/249 | <0.05 | ||
BMI ≥ 25 | 4 | (16.0%) | 54 | (12.6%) | NS |
History of liver diseases (yes) | 15 | (60.0%) | 143 | (33.3%) | <0.01 |
Alcohol consumption (yes) | 13 | (52.0%) | 214 | (49.9%) | NS |
History of smoking (yes) | 13 | (52.0%) | 139 | (32.4%) | <0.05 |
AST (IU/L) (mean ± SD) | 47.0 ± 45.8 | 23.6 ± 14.7 | <0.01 | ||
ALT (IU/L) (mean ± SD) | 44.0 ± 71.2 | 22.8 ± 21.4 | NS | ||
Anti-HCV, positive | 14 | (56.0%) | 96 | (22.4%) | 0.0001 |
HCV RNA, positive | 11 | (44.0%) | 67 | (15.6%) | <0.001 |
HBsAg, positive | 1 | (4.0%) | 9 | (2.1%) | NS |
Death by 2002 | 17 | (68.0%) | 52 | (12.1%) | <0.00001 |